Company Filing History:
Years Active: 2021-2022
Title: Colin Malone: Innovator in Gag-based Capsid Technology
Introduction
Colin Malone is a prominent inventor based in Brooklyn, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for gene editing and delivery systems.
Latest Patents
Colin Malone holds 3 patents, with his latest inventions focusing on endogenous Gag-based capsids. These patents detail the isolation of nucleic acids encoding endogenous Gag peptides from various organisms, including human DNA. The technology allows for the expression of endogenous Gag polypeptides that can be assembled into capsids. These capsids are designed to package and deliver nucleic acid molecules, facilitating advancements in gene editing, such as components involved in the CRISPR-Cas system.
Career Highlights
Colin Malone has established himself as a key figure in his field through his innovative research and development efforts. His work has the potential to revolutionize gene delivery systems, making significant strides in therapeutic applications.
Collaborations
Colin collaborates with talented individuals such as Zachary Gilbert and Ian Peikon, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Colin Malone's work in Gag-based capsid technology exemplifies the intersection of biotechnology and innovation. His contributions are paving the way for future advancements in gene editing and therapeutic delivery systems.